scispace - formally typeset
F

Fabrizio Tagliavini

Researcher at Carlo Besta Neurological Institute

Publications -  422
Citations -  21532

Fabrizio Tagliavini is an academic researcher from Carlo Besta Neurological Institute. The author has contributed to research in topics: Frontotemporal dementia & Amyloid. The author has an hindex of 73, co-authored 380 publications receiving 18785 citations. Previous affiliations of Fabrizio Tagliavini include University of Parma & Laval University.

Papers
More filters
Patent

Method for the diagnosis of pathologies characterised by the anomalous deposition of amyloid in organs and tissues by detecting a mutation at position 673 in app770, and vector and peptide for use in the therapy of said pathologies

TL;DR: In this paper, a screening method carried out on biological material isolated from human and/or animal organisms for determining the risk of human and animal pathologies expressing an anomalous deposition of β-amyloid and or amyloid-like substance in human or animal organs and tissues, based on the investigation of the punctiform mutation Ala>Val in position 2 of the β-protein (corresponding to the Ala673Val mutation precursor of theβ-protein containing 770 amino acids) in homozygosis or in heterozygosis.
Proceedings ArticleDOI

Robust MR-free Grey Matter Extraction in Amyloid PET/CT Studies with Deep Learning

TL;DR: In this paper, a method based on deep learning was proposed for segmentation of amyloid PET studies using U-Net for a validation cohort of N=20 patients, even when using only N=14 patients in the training dataset.
Journal ArticleDOI

Aβ1-6A2V(D) peptide, effective on Aβ aggregation, inhibits tau misfolding and protects the brain after traumatic brain injury.

TL;DR: In this article , the potential therapeutic capacity of an all-D-isomer synthetic peptide limited to the first six amino acids of the N-terminal sequence of the A2V-mutated Aβ, Aβ1-6A2V(D), was explored.